T1	Participants 305 316	40 patients
T2	Participants 633 799	37 patients who completed the trial 16 out of 19 (84%) of the patients in the Grenz ray group, and 13 out of 18 (72%) of the patients in the combination group healed.
T3	Participants 1090 1105	scalp psoriasis
